Medical use of cannabis for dry eye disease

(November 2018)

Background

The clinical value of cannabis in alleviating the symptoms of dry eye disease (DED) is limited at this time due to a lack of clinical evidence.

The Canadian Ophthalmological Society does not support the medical use of cannabis for the treatment of DED or its associated pain symptoms, due to its undesirable side-effects, including dry eye symptoms if smoked, and the absence of scientific evidence showing any beneficial effect at this time.

Other evidence-based, less harmful treatment modalities are available for DED and its associated symptoms.

Access Details

Read the full position statement and recommendations from the Canadian Ophthalmological Society (COS).

Related Resources

So You Got a Complaint – Now What?!

Articles Patients’ complaints involving ophthalmologists in the province of Ontario,...

More Info

Immediate Sequential Bilateral Cataract Surgery (ISBCS) COVID-19 Considerations

Updated March, 2021 This document, which is subject to regular...

More Info

COVID-19 Vaccination Tool Kit for Health Care Providers

The current edition of the tool kit includes information on...

More Info

Why Do My Eyes Burn When I Cry? Causes and Treatments healthline.com/health/eye-hea… via @Healthline

About 2 hours ago from Can Ophthal Society's Twitter via Twitter for Android

Can Ophthal Society's Twitter via Twitter Web Client